Unfortunately, we don't support Internet Explorer anymore as it has been replaced by Microsoft Edge. Please try using Edge or an alternative modern browser for the best experience.
8-00 AM – 8-30 AM
Registration and Networking
8-30 AM – 8-40 AM
Welcome address: Karun Rishi, President, USAIC
Opening comments: Dr. Andrew Plump, President of Research & Development, Takeda
8-40 AM – 9-20 AM
Panel: The State of BioPharma: Bold Bets, Big Shifts, and What Lies Ahead
Panelists:
Christopher Viehbacher, President & CEO, Biogen
Dr. Elias Zerhouni, Vice Chairman & President, OPKO Health
Hari Bhartia, Founder & Co-Chairman, Jubilant Bhartia Group
Moderator:
Daphne Zohar, Founder & Chief Executive Officer, Seaport Therapeutics
9-20 AM – 10-05 AM
Panel: Turning Breakthroughs into Impact: Unlocking the Rare & Neuro Opportunity
Panelists:
Dr. Al Sandrock, President & CEO, Voyager Therapeutics
Dr. David Meeker, Chairman & CEO, Rhythm Pharmaceuticals
Dr. Ivana Magovcevic-Liebisch, President & CEO, Draig Therapeutics
Dr. Priya Singhal, Executive Vice President & Head of Development, Biogen
Dr. Steven Paul, Founder and Chair of the Board, Seaport Therapeutics
Moderator:
Dr. Zandy Forbes, President & CEO, MeiraGTx
10-05 AM –10-45 AM
Panel: Expanding Horizons: The India Opportunity in Clinical Trials
Panelists:
Dr. Christoph Koenen, Head of Global Dev.& Clinical Operations, Bayer
Maria Koutsopoulou, SVP, Head of Global Development Operations, Merck KGaA
Peyton Howell, Chief Executive Officer, Parexel
Dr. Sanjay Mittal, Vice Chairman – Clinical Cardiology & Research, Medanta – The Medicity
Dr. Sarah Sheikh, Head of Global Development, Takeda
Moderator:
Dr. Uli Broedl, Head of Research & Development, Chief Scientific Officer, Grünenthal
10-45 AM – 11-15 AM
Networking Break
11-15 AM – 12-00 PM
Panel: Global Partnerships & U.S. Leadership in BioPharma Supply & Manufacturing
Panelists:
Dr. Dave Maraldo, Senior Vice President, Human Health Manufacturing, Merck & Co.
Edgardo Hernandez, EVP & President of Manufacturing Operations, Eli Lilly and Company
Mike McDermott, Executive Vice President, Chief Global Supply & Quality Officer, Pfizer
Dr. Rao Mantri, Chief Manufacturing Officer, Astellas
Moderator:
Sanat Chattopadhyay, President- Manufacturing, Merck & Co.
12-00 PM – 12-45 PM
Panel: Navigating Risk, Reward, and Innovation in BioPharma Investing
Panelists:
Dr. Eric Schmidt, Senior Research Analyst, Cantor Fitzgerald
Dr. Kris Jenner, Co-Founder & Managing Member, Rock Springs Capital
Rajiv Kaul, Sector Portfolio Manager, Fidelity Investments
Dr. Stephen Knight, President & Senior Managing Partner, F-Prime Capital
Moderator:
Dr. Stelios Papadopoulos, Chairman of the Board, Exelixis, Inc.
12-45 PM – 1-45 PM
Lunch
1-45 PM – 2-30 PM
Panel: The Next Oncology Wave: Where Value Wins and Only the Fittest Survive
Panelists:
Dr. Gary Nabel, Co-Founder & Chief Executive Officer, ModeX Therapeutics
Dr. Najat Khan, Chief Executive Officer and President, Recursion
Dr. Paul Peter Tak, President & CEO, Candel Therapeutics
Dr. Mathai Mammen, Chairman & CEO, Parabilis Medicines
Dr. Sam Waksal, Founder, Chairman & CEO, Graviton Biosciences
Moderator:
Dr. Claire Mazumdar, Chief Executive Officer, Bicara Therapeutics
2-30 PM – 3-15 PM
Panel: R&D Strategies and Trends
Panelists:
Dr. Andrew Plump, President of Research & Development, Takeda
Dr. George Yancopoulos, Co-Founder, Co-Chair, President and CSO, Regeneron
Dr. Gregory Verdine, Co-Founder & CEO, LifeMine Therapeutics
Dr. Tadaaki Taniguchi, Chief Research & Development Officer, Astellas
Moderator:
Dr. Martin Mackay, Co-Founder, Rallybio
3-15 PM – 3-45 PM
Networking Break
3-45 PM – 4-30 PM
Panel: AI in BioPharma R&D – Hype vs. Reality
Panelists:
Dr. Dina Katabi, Professor of Computer Science, MIT
Gianluca Pettiti, President and Chief Operating Officer, Thermo Fisher Scientific
Dr. Jason Kelly, Co-Founder & CEO, Ginkgo Bioworks
Dr. Justine Rochon, Senior Vice President, R&D Data and Quantitative Science, Takeda
Dr. Paul Burton, Chief Medical Officer, Amgen
Moderator:
Sastry Chilukuri, Chairman & CEO, Emmes Group
4-30 PM –4-35PM
Closing Remarks: Dr Andrew Plump, President of Research & Development, Takeda
4-35 PM – 5-15 PM
Honouring Dr. Elias Zerhouni, Vice Chairman, OPKO Health with the Distinguished Service Award
Tributes by:
Dr. Elizabeth Nabel, Advisory Board Chair, OPKO Health
Rainer Blair, President & CEO, Danaher
Dr. John Reed, Executive Vice President, Innovative Medicine, R&D, Johnson & Johnson
Dr. George Yancopoulos, Co-Founder, Co-Chair, President and CSO, Regeneron
Dr. Gary Nabel, Co-Founder & Chief Executive Officer, ModeX Therapeutics
Dr. Andrew Plump, President of Research & Development, Takeda
Christopher Viehbacher, President & CEO, Biogen
5-15 PM – 6-15 PM
Networking Reception
*Program and Speakers subject to change
